Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis
Dysfunction of the blood-brain barrier (BBB) is a primary characteristic of experimental autoimmune encephalomyelitis (EAE), an experimental model of multiple sclerosis (MS). Matrine (MAT), a quinolizidine alkaloid derived from the herb Radix Sophorae Flave, has been recently found to suppress clini...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/736085 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832566667255742464 |
---|---|
author | Su Zhang Quan-Cheng Kan Yuming Xu Guang-Xian Zhang Lin Zhu |
author_facet | Su Zhang Quan-Cheng Kan Yuming Xu Guang-Xian Zhang Lin Zhu |
author_sort | Su Zhang |
collection | DOAJ |
description | Dysfunction of the blood-brain barrier (BBB) is a primary characteristic of experimental autoimmune encephalomyelitis (EAE), an experimental model of multiple sclerosis (MS). Matrine (MAT), a quinolizidine alkaloid derived from the herb Radix Sophorae Flave, has been recently found to suppress clinical EAE and CNS inflammation. However, whether this effect of MAT is through protecting the integrity and function of the BBB is not known. In the present study, we show that MAT treatment had a therapeutic effect comparable to dexamethasone (DEX) in EAE rats, with reduced Evans Blue extravasation, increased expression of collagen IV, the major component of the basement membrane, and the structure of tight junction (TJ) adaptor protein Zonula occludens-1 (ZO-1). Furthermore, MAT treatment attenuated expression of matrix metalloproteinase-9 and -2 (MMP-9/-2), while it increased the expression of tissue inhibitors of metalloproteinase-1 and -2 (TIMP-1/-2). Our findings demonstrate that MAT reduces BBB leakage by strengthening basement membrane, inhibiting activities of MMP-2 and -9, and upregulating their inhibitors. Taken together, our results identify a novel mechanism underlying the effect of MAT, a natural compound that could be a novel therapy for MS. |
format | Article |
id | doaj-art-2d5504fe6cdb4f7693d34d0cbcaa3951 |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2013-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-2d5504fe6cdb4f7693d34d0cbcaa39512025-02-03T01:03:30ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/736085736085Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune EncephalomyelitisSu Zhang0Quan-Cheng Kan1Yuming Xu2Guang-Xian Zhang3Lin Zhu4Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, ChinaDepartment of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, ChinaDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, ChinaDepartment of Neurology, Thomas Jefferson University, Philadelphia, PA 19107, USADepartment of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, ChinaDysfunction of the blood-brain barrier (BBB) is a primary characteristic of experimental autoimmune encephalomyelitis (EAE), an experimental model of multiple sclerosis (MS). Matrine (MAT), a quinolizidine alkaloid derived from the herb Radix Sophorae Flave, has been recently found to suppress clinical EAE and CNS inflammation. However, whether this effect of MAT is through protecting the integrity and function of the BBB is not known. In the present study, we show that MAT treatment had a therapeutic effect comparable to dexamethasone (DEX) in EAE rats, with reduced Evans Blue extravasation, increased expression of collagen IV, the major component of the basement membrane, and the structure of tight junction (TJ) adaptor protein Zonula occludens-1 (ZO-1). Furthermore, MAT treatment attenuated expression of matrix metalloproteinase-9 and -2 (MMP-9/-2), while it increased the expression of tissue inhibitors of metalloproteinase-1 and -2 (TIMP-1/-2). Our findings demonstrate that MAT reduces BBB leakage by strengthening basement membrane, inhibiting activities of MMP-2 and -9, and upregulating their inhibitors. Taken together, our results identify a novel mechanism underlying the effect of MAT, a natural compound that could be a novel therapy for MS.http://dx.doi.org/10.1155/2013/736085 |
spellingShingle | Su Zhang Quan-Cheng Kan Yuming Xu Guang-Xian Zhang Lin Zhu Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis Mediators of Inflammation |
title | Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis |
title_full | Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis |
title_fullStr | Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis |
title_full_unstemmed | Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis |
title_short | Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis |
title_sort | inhibitory effect of matrine on blood brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis |
url | http://dx.doi.org/10.1155/2013/736085 |
work_keys_str_mv | AT suzhang inhibitoryeffectofmatrineonbloodbrainbarrierdisruptionforthetreatmentofexperimentalautoimmuneencephalomyelitis AT quanchengkan inhibitoryeffectofmatrineonbloodbrainbarrierdisruptionforthetreatmentofexperimentalautoimmuneencephalomyelitis AT yumingxu inhibitoryeffectofmatrineonbloodbrainbarrierdisruptionforthetreatmentofexperimentalautoimmuneencephalomyelitis AT guangxianzhang inhibitoryeffectofmatrineonbloodbrainbarrierdisruptionforthetreatmentofexperimentalautoimmuneencephalomyelitis AT linzhu inhibitoryeffectofmatrineonbloodbrainbarrierdisruptionforthetreatmentofexperimentalautoimmuneencephalomyelitis |